These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26506318)

  • 1. Determinants of tuberculosis in Brazil: from conceptual framework to practical application.
    Maciel EL; Reis-Santos B
    Rev Panam Salud Publica; 2015 Jul; 38(1):28-34. PubMed ID: 26506318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis.
    Prado TN; Rajan JV; Miranda AE; Dias ED; Cosme LB; Possuelo LG; Sanchez MN; Golub JE; Riley LW; Maciel EL
    Braz J Infect Dis; 2017; 21(2):162-170. PubMed ID: 27936379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of tuberculosis patients in Brazilian prisons: a polytomous regression analysis.
    Ribeiro Macedo L; Reis-Santos B; Riley LW; Maciel EL
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1427-34. PubMed ID: 24125446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of unsuccessful tuberculosis treatment outcomes in Brazil: an analysis of 259,484 patient records.
    Ryuk DK; Pelissari DM; Alves K; Oliveira PB; Castro MC; Cohen T; Sanchez M; Menzies NA
    BMC Infect Dis; 2024 May; 24(1):531. PubMed ID: 38802744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes of MDR-tuberculosis patients in Brazil: a retrospective cohort analysis.
    Bastos ML; Cosme LB; Fregona G; do Prado TN; Bertolde AI; Zandonade E; Sanchez MN; Dalcolmo MP; Kritski A; Trajman A; Maciel ELN
    BMC Infect Dis; 2017 Nov; 17(1):718. PubMed ID: 29137626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead.
    van Maaren PJ
    Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.
    Garrido Mda S; Bührer-Sékula S; Souza AB; de Oliveira GP; Antunes IA; Mendes JM; Saraceni V; Martinez-Espinosa FE; Ramasawmy R
    Int J Tuberc Lung Dis; 2015 May; 19(5):531-6. PubMed ID: 25868020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Later emergence of acquired drug resistance and its effect on treatment outcome in patients treated with Standard Short-Course Chemotherapy for tuberculosis.
    Gao J; Ma Y; Du J; Zhu G; Tan S; Fu Y; Ma L; Zhang L; Liu F; Hu D; Zhang Y; Li X; Li L; Li Q
    BMC Pulm Med; 2016 Feb; 16():26. PubMed ID: 26846562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    Emani S; Alves K; Alves LC; da Silva DA; Oliveira PB; Castro MC; Cohen T; Couto RM; Sanchez M; Menzies NA
    PLoS Med; 2024 Mar; 21(3):e1004361. PubMed ID: 38512968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistant tuberculosis in six hospitals in Rio de Janeiro, Brazil.
    Brito RC; Mello FC; Andrade MK; Oliveira H; Costa W; Matos HJ; Lourenço MC; Rolla VC; Fonseca L; Ruffino Netto A; Kritski AL
    Int J Tuberc Lung Dis; 2010 Jan; 14(1):24-33. PubMed ID: 20003691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extensively drug-resistant tuberculosis in the United States, 1993-2007.
    Shah NS; Pratt R; Armstrong L; Robison V; Castro KG; Cegielski JP
    JAMA; 2008 Nov; 300(18):2153-60. PubMed ID: 19001626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Special Tuberculosis Treatment Information System (SITE-TB) in Brazil: background, description and perspectives.
    Bartholomay P; Pinheiro RS; Pelissari DM; Arakaki-Sanchez D; Dockhorn F; Rocha JL; Penna EQAA; Barreira D; Araújo WN; Dalcolmo M
    Epidemiol Serv Saude; 2019 Jun; 28(2):e2018158. PubMed ID: 31271632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of tuberculosis transmission and treatment abandonment in Fortaleza, Brazil.
    Harling G; Lima Neto AS; Sousa GS; Machado MMT; Castro MC
    BMC Public Health; 2017 May; 17(1):508. PubMed ID: 28545423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with loss to follow-up and death in cases of drug-resistant tuberculosis (DR-TB) treated at a reference center in Rio de Janeiro, Brazil.
    Viana PVS; Redner P; Ramos JP
    Cad Saude Publica; 2018 May; 34(5):e00048217. PubMed ID: 29768580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of pediatric multidrug-resistant tuberculosis and latent tuberculosis infections in New York City from 1995 to 2003.
    Feja K; McNelley E; Tran CS; Burzynski J; Saiman L
    Pediatr Infect Dis J; 2008 Oct; 27(10):907-12. PubMed ID: 18756183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and factors associated with tuberculosis treatment outcome among hazardous or harmful alcohol users in public primary health care in South Africa.
    Peltzer K; Louw JS
    Afr Health Sci; 2014 Mar; 14(1):157-66. PubMed ID: 26060473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review.
    Di Gennaro F; Pizzol D; Cebola B; Stubbs B; Monno L; Saracino A; Luchini C; Solmi M; Segafredo G; Putoto G; Veronese N
    Tuberculosis (Edinb); 2017 Mar; 103():44-51. PubMed ID: 28237033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and treatment outcomes among patients with tuberculosis in Bangkok and Nonthaburi, Thailand.
    Manosuthi W; Kawkitinarong K; Suwanpimolkul G; Chokbumrungsuk C; Jirawattanapisal T; Ruxrungtham K; Akksilp S
    Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1426-36. PubMed ID: 23413706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.